Trials / Conditions / Cutaneous T-Cell Lymphoma Refractory
Cutaneous T-Cell Lymphoma Refractory
4 registered clinical trials studyying Cutaneous T-Cell Lymphoma Refractory — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cuta NCT07535710 | Shanghai Jiao Tong University School of Medicine | Phase 1 / Phase 2 |
| Recruiting | Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) NCT06810778 | Jonsson Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Unknown | Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T NCT04712864 | Legend Biotech USA Inc | Phase 1 |
| Active Not Recruiting | Mogamulizumab Q4week Dosing in Participants With R/R CTCL NCT04745234 | Kyowa Kirin, Inc. | Phase 2 |